“rhenium Re 188 BMEDA-liposome”的概念、定义、翻译、参考文献-科学参考

A liposome-based preparation consisting of the beta- and gamma-emitting radionuclide rhenium Re 188 (Re 188) linked to the chelator N,N-bis (2-mercaptoethyl)-N',N'-diethylethylenediamine (BMEDA) and encapsulated in liposomes, with potential tumor imaging and antineoplastic activities. Upon intravenous infusion of rhenium Re 188 BMEDA-labeled liposomes, the liposomes selectively target tumor cells, facilitate the retention of the radioisotope by those cells, and cause localized antitumor radiocytotoxicity while sparing surrounding normal, healthy cells. In addition, Re 188 BMEDA-labeled liposomes can be used for imaging purposes. Re 188 has a short half-life and a short path length, which further contribute to limiting the radiotoxicity to the tumor cells. Check foractive clinical trials using this agent.

单词	rhenium Re 188 BMEDA-liposome
释义	rhenium Re 188 BMEDA-liposome A liposome-based preparation consisting of the beta- and gamma-emitting radionuclide rhenium Re 188 (Re 188) linked to the chelator N,N-bis (2-mercaptoethyl)-N',N'-diethylethylenediamine (BMEDA) and encapsulated in liposomes, with potential tumor imaging and antineoplastic activities. Upon intravenous infusion of rhenium Re 188 BMEDA-labeled liposomes, the liposomes selectively target tumor cells, facilitate the retention of the radioisotope by those cells, and cause localized antitumor radiocytotoxicity while sparing surrounding normal, healthy cells. In addition, Re 188 BMEDA-labeled liposomes can be used for imaging purposes. Re 188 has a short half-life and a short path length, which further contribute to limiting the radiotoxicity to the tumor cells. Check foractive clinical trials using this agent.
随便看	synthesis phase synthetic synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine synthetic breast cancer peptides-tetanus toxoid-poly ICLC vaccine synthetic colorectal tumor-associated peptides vaccine IMA910 synthetic glioblastoma mutated tumor-specific peptides vaccine therapy APVAC2 synthetic glioblastoma tumor-associated peptides vaccine therapy APVAC1 synthetic hTERT DNA vaccine INO-1400 synthetic human papillomavirus 16 E6 peptide synthetic human secretin synthetic human secretin synthetic hypericin synthetic long E6/E7 peptides vaccine HPV-01 synthetic melanoma-associated antigens vaccine synthetic peptide-based erythropoiesis stimulating agent synthetic peptides E-PRA and E-PSM vaccine synthetic protegrin analog synthetic retinoid Synthoestrin Synthroid Synthroid Syntocinon syringe systematics